| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.87e-05 | 26 | 46 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.48e-05 | 171 | 46 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 5.17e-05 | 5 | 46 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.34e-04 | 52 | 46 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | sodium ion binding | 4.64e-04 | 14 | 46 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.57e-04 | 465 | 46 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 7.54e-04 | 664 | 46 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR2B11 OR2K2 OR5T1 UTS2R HTR4 NRXN1 ITGAL NRXN2 OR9G4 OR5AL1 | 8.50e-04 | 1353 | 46 | 10 | GO:0004888 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.12e-03 | 343 | 46 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 1.27e-03 | 23 | 46 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.63e-03 | 758 | 46 | 7 | GO:0015318 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.63e-03 | 26 | 46 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.82e-03 | 105 | 46 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 2.03e-03 | 29 | 46 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.10e-03 | 793 | 46 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 2.94e-03 | 35 | 46 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.01e-03 | 627 | 46 | 6 | GO:0022890 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 3.03e-03 | 431 | 46 | 5 | GO:0004984 | |
| GeneOntologyMolecularFunction | odorant binding | 3.12e-03 | 127 | 46 | 3 | GO:0005549 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 3.85e-03 | 884 | 46 | 7 | GO:0004930 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.96e-03 | 459 | 46 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 5.09e-03 | 1180 | 46 | 8 | GO:0022857 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 6.88e-03 | 54 | 46 | 2 | GO:0005246 | |
| GeneOntologyMolecularFunction | channel activity | 6.95e-03 | 525 | 46 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 7.01e-03 | 526 | 46 | 5 | GO:0022803 | |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 2.91e-05 | 4 | 46 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | gephyrin clustering involved in postsynaptic density assembly | 4.85e-05 | 5 | 46 | 2 | GO:0097116 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 7.04e-05 | 36 | 46 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 9.73e-05 | 208 | 46 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | vocal learning | 1.01e-04 | 7 | 46 | 2 | GO:0042297 | |
| GeneOntologyBiologicalProcess | imitative learning | 1.01e-04 | 7 | 46 | 2 | GO:0098596 | |
| GeneOntologyBiologicalProcess | observational learning | 1.73e-04 | 9 | 46 | 2 | GO:0098597 | |
| GeneOntologyBiologicalProcess | postsynaptic density protein 95 clustering | 2.64e-04 | 11 | 46 | 2 | GO:0097119 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 2.64e-04 | 11 | 46 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | learned vocalization behavior or vocal learning | 2.64e-04 | 11 | 46 | 2 | GO:0098598 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 3.56e-04 | 275 | 46 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 3.58e-04 | 62 | 46 | 3 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 3.75e-04 | 63 | 46 | 3 | GO:0019228 | |
| GeneOntologyBiologicalProcess | auditory behavior | 4.35e-04 | 14 | 46 | 2 | GO:0031223 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 5.72e-04 | 16 | 46 | 2 | GO:0007158 | |
| GeneOntologyBiologicalProcess | mechanosensory behavior | 6.48e-04 | 17 | 46 | 2 | GO:0007638 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 7.09e-06 | 17 | 47 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 3.74e-05 | 29 | 47 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 7.20e-04 | 78 | 47 | 3 | GO:0048787 | |
| Domain | Na_channel_asu | 1.17e-06 | 10 | 41 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 1.17e-06 | 10 | 41 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 1.17e-06 | 10 | 41 | 3 | PF06512 | |
| Domain | Na_trans_cytopl | 7.01e-05 | 6 | 41 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 7.01e-05 | 6 | 41 | 2 | IPR024583 | |
| Domain | Syndecan | 9.81e-05 | 7 | 41 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 9.81e-05 | 7 | 41 | 2 | IPR027789 | |
| Domain | Ion_trans_dom | 1.12e-04 | 114 | 41 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.12e-04 | 114 | 41 | 4 | PF00520 | |
| Domain | Channel_four-helix_dom | 2.65e-04 | 57 | 41 | 3 | IPR027359 | |
| Domain | - | 2.65e-04 | 57 | 41 | 3 | 1.20.120.350 | |
| Domain | Neurexin-like | 4.21e-04 | 14 | 41 | 2 | IPR003585 | |
| Domain | 4.1m | 4.21e-04 | 14 | 41 | 2 | SM00294 | |
| Domain | IQ | 5.06e-04 | 71 | 41 | 3 | PF00612 | |
| Domain | Disintegrin_CS | 5.53e-04 | 16 | 41 | 2 | IPR018358 | |
| Domain | ADAM_CR | 7.04e-04 | 18 | 41 | 2 | PF08516 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 7.04e-04 | 18 | 41 | 2 | PS00754 | |
| Domain | IQ | 7.44e-04 | 81 | 41 | 3 | SM00015 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 7.85e-04 | 19 | 41 | 2 | PS50267 | |
| Domain | SNF | 7.85e-04 | 19 | 41 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 7.85e-04 | 19 | 41 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 7.85e-04 | 19 | 41 | 2 | PS00610 | |
| Domain | - | 8.71e-04 | 20 | 41 | 2 | 4.10.70.10 | |
| Domain | DISIN | 9.62e-04 | 21 | 41 | 2 | SM00050 | |
| Domain | Disintegrin | 9.62e-04 | 21 | 41 | 2 | PF00200 | |
| Domain | IQ_motif_EF-hand-BS | 1.01e-03 | 90 | 41 | 3 | IPR000048 | |
| Domain | IQ | 1.11e-03 | 93 | 41 | 3 | PS50096 | |
| Domain | ADAM_Cys-rich | 1.59e-03 | 27 | 41 | 2 | IPR006586 | |
| Domain | ACR | 1.59e-03 | 27 | 41 | 2 | SM00608 | |
| Domain | EGF_3 | 1.72e-03 | 235 | 41 | 4 | PS50026 | |
| Domain | EGF-like_dom | 2.12e-03 | 249 | 41 | 4 | IPR000742 | |
| Domain | EGF_1 | 2.31e-03 | 255 | 41 | 4 | PS00022 | |
| Domain | EGF-like_CS | 2.51e-03 | 261 | 41 | 4 | IPR013032 | |
| Domain | EGF_2 | 2.66e-03 | 265 | 41 | 4 | PS01186 | |
| Domain | LAM_G_DOMAIN | 3.14e-03 | 38 | 41 | 2 | PS50025 | |
| Domain | GPCR_Rhodpsn_7TM | 3.21e-03 | 670 | 41 | 6 | IPR017452 | |
| Domain | Peptidase_M12B_N | 3.31e-03 | 39 | 41 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 3.31e-03 | 39 | 41 | 2 | PF01562 | |
| Domain | 7tm_1 | 3.38e-03 | 677 | 41 | 6 | PF00001 | |
| Domain | DISINTEGRIN_1 | 3.48e-03 | 40 | 41 | 2 | PS00427 | |
| Domain | Laminin_G_2 | 3.48e-03 | 40 | 41 | 2 | PF02210 | |
| Domain | ADAM_MEPRO | 3.48e-03 | 40 | 41 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.48e-03 | 40 | 41 | 2 | PS50214 | |
| Domain | Reprolysin | 3.48e-03 | 40 | 41 | 2 | PF01421 | |
| Domain | Peptidase_M12B | 3.48e-03 | 40 | 41 | 2 | IPR001590 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 3.58e-03 | 685 | 41 | 6 | PS00237 | |
| Domain | Disintegrin_dom | 3.65e-03 | 41 | 41 | 2 | IPR001762 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 3.74e-03 | 691 | 41 | 6 | PS50262 | |
| Domain | GPCR_Rhodpsn | 3.77e-03 | 692 | 41 | 6 | IPR000276 | |
| Domain | LamG | 4.20e-03 | 44 | 41 | 2 | SM00282 | |
| Domain | Laminin_G | 7.19e-03 | 58 | 41 | 2 | IPR001791 | |
| Domain | EGF_extracell | 7.68e-03 | 60 | 41 | 2 | IPR013111 | |
| Domain | EGF_2 | 7.68e-03 | 60 | 41 | 2 | PF07974 | |
| Domain | Olfact_rcpt | 1.06e-02 | 393 | 41 | 4 | IPR000725 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.57e-05 | 31 | 32 | 3 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 5.04e-05 | 32 | 32 | 3 | M27455 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 1.53e-04 | 367 | 32 | 6 | M48346 | |
| Pubmed | 1.93e-07 | 9 | 47 | 3 | 16382098 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 18079277 | ||
| Pubmed | Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. | 1.79e-06 | 2 | 47 | 2 | 1621094 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 30709877 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 1.79e-06 | 2 | 47 | 2 | 27174182 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 26595880 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24951661 | ||
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 5.36e-06 | 3 | 47 | 2 | 34133920 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 38891114 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 5.36e-06 | 3 | 47 | 2 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 5.36e-06 | 3 | 47 | 2 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 5.36e-06 | 3 | 47 | 2 | 29045040 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 31005376 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 38571813 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 35173587 | ||
| Pubmed | Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. | 5.36e-06 | 3 | 47 | 2 | 21424692 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 30858964 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 5.36e-06 | 3 | 47 | 2 | 7722633 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 5.36e-06 | 3 | 47 | 2 | 26446217 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 28013231 | ||
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 5.36e-06 | 3 | 47 | 2 | 11944992 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 16406382 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 5.36e-06 | 3 | 47 | 2 | 17035546 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 5.36e-06 | 3 | 47 | 2 | 25423136 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 31812984 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 20038812 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 15302875 | ||
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 1.07e-05 | 4 | 47 | 2 | 14983056 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 8786425 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 17347997 | ||
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 1.07e-05 | 4 | 47 | 2 | 32134527 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 32706374 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 21192791 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 35385735 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 1.07e-05 | 4 | 47 | 2 | 33888718 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 28472659 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 36709330 | ||
| Pubmed | Pro-apoptotic function of checkpoint kinase-2 in syncytia elicited by the HIV-1 envelope. | 1.78e-05 | 5 | 47 | 2 | 19177012 | |
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 1.78e-05 | 5 | 47 | 2 | 18923512 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 20537373 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.78e-05 | 5 | 47 | 2 | 22875929 | |
| Pubmed | Do checkpoint kinases contribute to HIV-1-mediated apoptosis? | 1.78e-05 | 5 | 47 | 2 | 19164952 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 9223334 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 17724025 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 16029194 | ||
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 2.67e-05 | 6 | 47 | 2 | 8576240 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 30683685 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 2.67e-05 | 6 | 47 | 2 | 23652591 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 2.67e-05 | 6 | 47 | 2 | 12827191 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 4.98e-05 | 8 | 47 | 2 | 30871858 | |
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 37591863 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 21356198 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 15746173 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 9707552 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 34919427 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 9.50e-05 | 340 | 47 | 5 | 11875048 | |
| Pubmed | 9.50e-05 | 340 | 47 | 5 | 11802173 | ||
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 32973045 | ||
| Pubmed | 9.89e-05 | 343 | 47 | 5 | 32295537 | ||
| Pubmed | 1.03e-04 | 346 | 47 | 5 | 14611657 | ||
| Pubmed | 1.38e-04 | 13 | 47 | 2 | 15123669 | ||
| Pubmed | The contribution of rare and common variants in 30 genes to risk nicotine dependence. | 1.61e-04 | 14 | 47 | 2 | 25450229 | |
| Pubmed | 2.12e-04 | 16 | 47 | 2 | 20010835 | ||
| Pubmed | The repertoire of solute carriers of family 6: identification of new human and rodent genes. | 3.69e-04 | 21 | 47 | 2 | 16125675 | |
| Pubmed | Cbln1 regulates axon growth and guidance in multiple neural regions. | 4.06e-04 | 22 | 47 | 2 | 36395107 | |
| Pubmed | Exploring the link between MORF4L1 and risk of breast cancer. | 4.84e-04 | 24 | 47 | 2 | 21466675 | |
| Pubmed | Neurogenesis requires TopBP1 to prevent catastrophic replicative DNA damage in early progenitors. | 4.84e-04 | 24 | 47 | 2 | 22522401 | |
| Pubmed | ATR maintains select progenitors during nervous system development. | 5.26e-04 | 25 | 47 | 2 | 22266795 | |
| Pubmed | 6.61e-04 | 28 | 47 | 2 | 38324473 | ||
| Pubmed | 6.61e-04 | 28 | 47 | 2 | 19352218 | ||
| Pubmed | 7.23e-04 | 300 | 47 | 4 | 19086053 | ||
| Pubmed | 7.34e-04 | 130 | 47 | 3 | 12421765 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 8.91e-04 | 139 | 47 | 3 | 16985003 | |
| Pubmed | 9.20e-04 | 1168 | 47 | 7 | 19946888 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 1.09e-03 | 1203 | 47 | 7 | 29180619 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 2.60e-04 | 120 | 47 | 3 | chr17q23 | |
| Cytoband | 17q23.3 | 4.38e-04 | 30 | 47 | 2 | 17q23.3 | |
| Cytoband | 11q12.1 | 6.13e-04 | 161 | 47 | 3 | 11q12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q32 | 3.08e-03 | 80 | 47 | 2 | chr5q32 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.20e-07 | 9 | 32 | 3 | 1203 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.04e-03 | 27 | 32 | 2 | 47 | |
| GeneFamily | Olfactory receptors, family 5 | 1.67e-02 | 112 | 32 | 2 | 152 | |
| GeneFamily | Olfactory receptors, family 2 | 1.70e-02 | 113 | 32 | 2 | 149 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 1.30e-05 | 634 | 46 | 8 | M40866 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-06 | 177 | 46 | 5 | aa56129d2d5a73a10e33b7162233a4d9337ee535 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-06 | 177 | 46 | 5 | d78a6003ce2d15d7771ae385de252eec7e3c3eea | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-06 | 177 | 46 | 5 | 70ca5b6fde2e38af1eb88a7d6e8746edba298191 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|COPD / Disease state, Lineage and Cell class | 2.13e-05 | 158 | 46 | 4 | 71af1319eec34bf7bc9361ec9ef720c280ce97d1 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 2.24e-05 | 160 | 46 | 4 | 1b73a14ad6546d9f2812c19081278a79260abeae | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.35e-05 | 162 | 46 | 4 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | Adult-Immune-dendritic_cell|Adult / Lineage, Cell type, age group and donor | 2.52e-05 | 165 | 46 | 4 | 073f52698dac1fe4edd7410865f81b30e1c7196a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 166 | 46 | 4 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 3.11e-05 | 174 | 46 | 4 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | Adult-Immune-dendritic_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.25e-05 | 176 | 46 | 4 | 1f0f1f953e6d61119f342de0d980aa1287511dba | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 181 | 46 | 4 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 181 | 46 | 4 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 181 | 46 | 4 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.20e-05 | 188 | 46 | 4 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.38e-05 | 190 | 46 | 4 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | COPD-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 4.47e-05 | 191 | 46 | 4 | 4e4887175200a57e1b041f2f131e3df774df3509 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.65e-05 | 193 | 46 | 4 | 00349d176fb6a46cbcc99c41d975651b6e9aaad4 | |
| ToppCell | medial-Hematologic-Plasmacytoid_Dendritic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.75e-05 | 194 | 46 | 4 | bb36274d6fe2d18c545a17d3809f331586502d01 | |
| ToppCell | medial-2-Hematologic-Plasmacytoid_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.75e-05 | 194 | 46 | 4 | d58be6454a0795d6771036a1620553a153861615 | |
| ToppCell | medial-Hematologic-Plasmacytoid_Dendritic-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.75e-05 | 194 | 46 | 4 | 0117cd68750153fd6b8978c8b4ce3589486d2b5f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.84e-05 | 195 | 46 | 4 | 31b011f3d54e6729802aad1f771cef77744e3ff2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.84e-05 | 195 | 46 | 4 | 36c784709ee32174e05b457500339c3b8eee3244 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.84e-05 | 195 | 46 | 4 | 06051de72b5c1e0d483a28b14dabd247dfca0ed9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.84e-05 | 195 | 46 | 4 | 3aa44633c72658545aa2b35bf9d532c62f36a451 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.04e-05 | 197 | 46 | 4 | f7eaac1c321710a55e09ffb047a7db2baf7b7e28 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.24e-05 | 199 | 46 | 4 | 86739a6f5e0fa7448389b97b3c4de41f2a7d7ebd | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.34e-05 | 200 | 46 | 4 | 553e9612874480f4d2a45671462e266cd0a09321 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.84e-04 | 107 | 46 | 3 | 13af691c8533418d2800a8eca61155896b559948 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.84e-04 | 107 | 46 | 3 | a5a34bb9706527799ddb494d4f1bfc634c29e8a9 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 2.84e-04 | 124 | 46 | 3 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.98e-04 | 126 | 46 | 3 | 83f3540683b3b175b10af059ab8898c46eaccc13 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.98e-04 | 126 | 46 | 3 | f20424f9baf3c4059cd6b701761e7595400fc47c | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.98e-04 | 126 | 46 | 3 | 6d5075d659dac7b96e6857f8485a7d2c4105d685 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.98e-04 | 126 | 46 | 3 | fd0001a0f3a0a4421f96fd21813c21cf6f01d40e | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.42e-04 | 132 | 46 | 3 | 893b7ec2a2d8a140cc98575d1beca1189f053e9a | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.32e-04 | 143 | 46 | 3 | 5a279da1cd8e63db32f7c85a73b493c2121d0a96 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.50e-04 | 145 | 46 | 3 | 997bd540c43725a85ca97e4b79ebe0d336860287 | |
| ToppCell | Adult-Immune-dendritic_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.68e-04 | 147 | 46 | 3 | 7cc4f74dd7a86247db8dc049ed7eadeb53825a96 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.87e-04 | 149 | 46 | 3 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.87e-04 | 149 | 46 | 3 | 1e77f03d2b32f366018fec3462d1b75f6e7febb9 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 5.06e-04 | 151 | 46 | 3 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | severe_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 5.16e-04 | 152 | 46 | 3 | ab5a4e47b23d16018642d4c9c7f41b30205edf73 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 154 | 46 | 3 | 3fa6f77ad2c30ec24b9b904e2732ec5b419dff5b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 154 | 46 | 3 | ee03b386d28a524084eaf1c0091f7389daa34250 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.46e-04 | 155 | 46 | 3 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-04 | 158 | 46 | 3 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-04 | 158 | 46 | 3 | df614450e10629dc9115d7365397663e82f9e48f | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.77e-04 | 158 | 46 | 3 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.88e-04 | 159 | 46 | 3 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.88e-04 | 159 | 46 | 3 | 2fb1d2ff52920aeb48d048cf29f0cd45f944a73d | |
| ToppCell | facs-Marrow-T-cells-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-04 | 160 | 46 | 3 | b3f7ef7e682b48a83ca425f5c439336e96168300 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-04 | 161 | 46 | 3 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-04 | 161 | 46 | 3 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-04 | 161 | 46 | 3 | 71022485da6754a2b57b4c3e758e3de4c95cc292 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.10e-04 | 161 | 46 | 3 | 98be0cf8228496b31f7f3e0efd8787e95eb626d1 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.10e-04 | 161 | 46 | 3 | 7af3b0d4fc7967f6b3e2d255d23fd8b1fd01a7af | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-04 | 161 | 46 | 3 | 59ae8a7c9a04ecaa335b8064852a5a91a21780bd | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-04 | 162 | 46 | 3 | e81dec1db8e5a808d96e58410c91961e5d065c94 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-04 | 162 | 46 | 3 | d19b469f64c9064cfb82dadb6c8135e28949a02a | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-04 | 162 | 46 | 3 | 10c2aa047f33f48e4abe676236bbdb593079dd1d | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-04 | 163 | 46 | 3 | 2a561aa4518cf52d8470eff083b84f942a2b2b5d | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-NK_CD56bright|Multiple_Sclerosis / Disease, Lineage and Cell Type | 6.32e-04 | 163 | 46 | 3 | 82c4b25f05bd404fdee9aa90f23efd6dffc04e7b | |
| ToppCell | COPD-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 6.43e-04 | 164 | 46 | 3 | a07c6e13c07a90bc37db0915eb14931eb8309a1e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-04 | 164 | 46 | 3 | 0853e75b60b2a78257b660910c3ee15b09c5f5b0 | |
| ToppCell | NS-critical-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.55e-04 | 165 | 46 | 3 | 17d5c4a111d9b5400780bc5e7b93ce2f5d69ceb7 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-04 | 166 | 46 | 3 | 6842735750dcb361e4c9844f05233b0fbb879652 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-04 | 166 | 46 | 3 | f742d15b02a6f651bbd00f53e3d871f40d05a03d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-04 | 166 | 46 | 3 | e941df9a1091164edde3def8fc7d410186b2bd88 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-04 | 166 | 46 | 3 | 7f4e5976ede6478636aa567d6fc2b56ff7295fb8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-04 | 166 | 46 | 3 | aeda46bea5d8463c24a83b98b9ed92d962d733e5 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-04 | 166 | 46 | 3 | 67370c49d7aedcb4eca802095f06b30f6bbf8919 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-04 | 166 | 46 | 3 | 0f013bb5fdb72e88c2fc73d60cd01551a2db6341 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.66e-04 | 166 | 46 | 3 | 0590e404f45afce90e20f93f90a3def83949c66b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.78e-04 | 167 | 46 | 3 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.90e-04 | 168 | 46 | 3 | d7d19c93d1c3dd994e18e28d5f36ae7773ff5d7f | |
| ToppCell | NS-moderate-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.90e-04 | 168 | 46 | 3 | d03e91f0e0518b33555c0ec98124fc5ed0f11be5 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.02e-04 | 169 | 46 | 3 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.14e-04 | 170 | 46 | 3 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-04 | 170 | 46 | 3 | 6210ee3bf29059e6149c047bb7e02c5f59441519 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.26e-04 | 171 | 46 | 3 | 4fd2c7977c512c51507f055fc74b111c0228ed8b | |
| ToppCell | COVID-19_Convalescent-cDC-|COVID-19_Convalescent / Disease condition and Cell class | 7.26e-04 | 171 | 46 | 3 | fb5fae8b3adafcbb7c5618d887966b418355ed4d | |
| ToppCell | COVID-19_Convalescent-cDC|COVID-19_Convalescent / Disease condition and Cell class | 7.26e-04 | 171 | 46 | 3 | 9ccaa9f1629818b0f63a5d930ee78c01e04cd98d | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-04 | 172 | 46 | 3 | 0c6332a806ac75fffae6080f61965555c7f687f4 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.51e-04 | 173 | 46 | 3 | b335ca2a247156eba821943b2b9fc9922230b409 | |
| ToppCell | mild_COVID-19_(asymptomatic)-gd_T|World / disease group, cell group and cell class (v2) | 7.51e-04 | 173 | 46 | 3 | b6615ff02f5017d7150b1e33b53f8c7a26081a0d | |
| ToppCell | Dendritic_Cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 7.51e-04 | 173 | 46 | 3 | ddb900ef4abeabe2e59db1009efc337e35d301fe | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-04 | 174 | 46 | 3 | a0641908ab6feaca5cd07142d7429983a2f68668 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.76e-04 | 175 | 46 | 3 | 393da565f61ba640410419a0cabaaf5c1056580a | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.76e-04 | 175 | 46 | 3 | 271b56d4ab940959d28ca4b86ce2750350dfc717 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.76e-04 | 175 | 46 | 3 | 8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.76e-04 | 175 | 46 | 3 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.76e-04 | 175 | 46 | 3 | 5168340c6045bbc7d67276afb719b051d1cb65a2 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-04 | 175 | 46 | 3 | ca2eabf03b70353e7eb15b6f622b2f9223a99e18 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 176 | 46 | 3 | 741fdacb33d49b030a797a6099fdea0949a22e75 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 7.89e-04 | 176 | 46 | 3 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 176 | 46 | 3 | dbb1c7cc6e404593b62e79b1fb815bc65ff49cae | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-04 | 177 | 46 | 3 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-04 | 177 | 46 | 3 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-04 | 177 | 46 | 3 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 177 | 46 | 3 | baf78a8dad55f124f56585f88b10b58c0269680f | |
| Drug | Dibucaine [85-79-0]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.21e-06 | 199 | 44 | 6 | 4068_UP | |
| Drug | Limber | 7.50e-06 | 20 | 44 | 3 | CID003083543 | |
| Drug | dibucaine | 9.03e-06 | 68 | 44 | 4 | CID000003025 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 1.09e-05 | 3 | 44 | 2 | ctd:C561228 | |
| Drug | Etifenin [63245-28-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 3.54e-05 | 194 | 44 | 5 | 2838_UP | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 3.90e-05 | 198 | 44 | 5 | 6073_UP | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 4.51e-07 | 10 | 47 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 4.51e-07 | 10 | 47 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 8.25e-07 | 12 | 47 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | B Virus Infection | 7.44e-06 | 3 | 47 | 2 | C0037140 | |
| Disease | Postherpetic neuralgia | 7.44e-06 | 3 | 47 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 7.44e-06 | 3 | 47 | 2 | C0019372 | |
| Disease | triacylglycerol 58:10 measurement | 2.19e-05 | 34 | 47 | 3 | EFO_0010437 | |
| Disease | Epilepsy | 7.06e-04 | 109 | 47 | 3 | C0014544 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LNSMKYVELYLVADY | 206 | Q9H013 | |
| LEIYIIVEKALYDYM | 186 | Q9Y3Q7 | |
| AFIQMALQLAYYRIY | 431 | P43155 | |
| LYFYQMLLAVQYLHE | 326 | O96017 | |
| LYYAFLMEYIVLNVG | 41 | O95424 | |
| YLNKCFYLTLEDMLY | 296 | Q5T5Y3 | |
| YAIVIEIMNRLYRYA | 366 | Q9NW15 | |
| AALCILILLYAMYKY | 406 | P58400 | |
| VLADLVMLTLYFYYK | 106 | Q6ZP29 | |
| DYHYIMENLFLYVIS | 206 | Q86WG3 | |
| YYLEILMVTGLLAYI | 136 | Q96A33 | |
| YYMLEVYLSQRNVAS | 681 | Q16549 | |
| AALCILILLYAMYKY | 1646 | Q9P2S2 | |
| YAELMGLKQVYYHVL | 161 | Q8IXM6 | |
| AALCILILLYAMYKY | 1411 | Q9ULB1 | |
| MSVKYHYELLNYIDL | 436 | Q9NVP1 | |
| IVSLFYLPAIYMYLQ | 251 | Q5JQS5 | |
| VVAYTECYLLAAMAY | 121 | Q8NGQ1 | |
| FLYGAMLYYELQTQL | 26 | O00461 | |
| LLAAMAYDRYVAIYN | 126 | Q8NG75 | |
| EMLIYLAQYLCSEYL | 256 | Q66K79 | |
| LLMVLAYYRIYVTAK | 206 | Q13639 | |
| KNMYYEALEAIETYL | 411 | Q9NR34 | |
| ALPELIYYIILYMQI | 356 | Q96P70 | |
| IYYIILYMQITEEQI | 361 | Q96P70 | |
| VLGDMLNIYYAYIQA | 176 | P0C7U9 | |
| YLGYFQAYNVLILTM | 396 | Q8IZK6 | |
| VVILYYGAALSMYLK | 246 | Q8NGT1 | |
| FYLINLILAVVAMAY | 436 | P35499 | |
| LQLTNTSAYYMYLLL | 131 | P0CF51 | |
| HLIRLLYDEYMYYLI | 876 | P22670 | |
| CELYLLSIMAYDRYV | 126 | P0C617 | |
| FYLINLILAVVAMAY | 391 | Q15858 | |
| MLLVLDLLYYSAMNY | 111 | Q3SXP7 | |
| VDVVYEKQMLYLYVL | 1081 | P20701 | |
| RAVDLMTHNYYELLY | 1071 | Q12769 | |
| VGLVAIYYNMIIAYV | 126 | Q99884 | |
| YMLLEELCQYYRTFV | 286 | Q5M7Z0 | |
| QLPMIYFLNHYLYDL | 236 | Q9H1C4 | |
| YASQMIVILLNVYYI | 116 | Q9NSD5 | |
| EAIYMQKVIYYLCIL | 126 | Q14442 | |
| YLVNLILAVVAMAYE | 401 | Q9UQD0 | |
| NFLMALLYYLSHYLE | 151 | Q96LQ0 | |
| YMLGILIYIQNSDYE | 656 | Q8NF64 | |
| MYVYVVNLALADLLY | 86 | Q9UKP6 | |
| SYAYILMVLYFLQQR | 1121 | Q5TAX3 | |
| VYCLRTEYIADYLMQ | 1461 | Q92547 | |
| LVLAYALHMLIYLRY | 161 | Q52LC2 | |
| ALHMLIYLRYLDQQY | 166 | Q52LC2 | |
| VELYYMILERLGKYQ | 196 | Q14CX7 |